Skip to main content
SanofiRecognition

CNS Summit Announces Sanofi as No. 1 in the 2026 Digital Innovation Index

Source: Autobound Signal API · 89 signals tracked for Sanofi · updated

Get Sanofi's live signals in Claude or ChatGPT, or by API

AskWhat changed at Sanofi this week? Use Autobound signals for sanofi.com.

What happened

Sanofi ranked first in the 2026 CNS Summit Digital Innovation Index.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

BOSTON, Nov. 4, 2026 /PRNewswire/ -- Sanofi ranked first in the 2026 CNS Summit Digital Innovation Index, developed in collaboration with IDEA Pharma, a division of SAI MedPartners, placing in the top three in all three categories. The rankings were revealed today on the CNS Summit 2026 main stage at Encore Boston Harbor. Now in its 11th year, the Index ranks the top 30 pharmaceutical companies on digital innovation, using publicly reported initiatives and investments from July 2025 through July 2026. The 2026 top 10 are Sanofi, Eli Lilly, AstraZeneca, Chugai, Roche, Bristol Myers Squibb, Novo Nordisk, Johnson & Johnson, Boehringer Ingelheim and Merck KGaA. Category leaders were Roche in commercial, Novo Nordisk in clinical development and Recursion in research. "Ranking first in the Pharmaceutical Digital Innovation Index reflects a shift we are proud of: digital and AI at Sanofi are now a connected system spanning research, clinical development and commercial operations. This is what allows us to move beyond AI experimentation to AI that delivers impact at scale, so that scientific breakthroughs reach patients faster," said Emmanuel Frenehard, Chief Digital Officer, Sanofi. CNS Summit's Chairman and Chief Curator, Dr. Amir Kalali, said, "Digital innovation is becoming more and more important in research and development. We are pleased to continue to support this...

Keep reading with a free account

The rest of this article, and every signal for Sanofi, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Recognition

What this signalsAnalyst or press recognition often comes during a period of growth.

Takes effect
Nov 4, 2026
Location
Boston, Massachusetts, United States

The full record

From the Signal API record

Details

Recognition
No. 1 in the 2026 CNS Summit Digital Innovation Index

Extraction

Confidence
95%
Detected
Nov 4, 2026
signal_type
news
signal_subtype
recognized_as

Use this data

Get every recognition signal for Sanofi and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Sanofi this week?”

  2. Send it to your own tools

    The Signal API returns recognition signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/a36e5ccf-6a0c-32a4-33b8-7590a492c574 returns this record as JSON. POST /v1/companies/enrich returns every signal for sanofi.com.

{
  "signal_id": "a36e5ccf-6a0c-32a4-33b8-7590a492c574",
  "signal_type": "news",
  "signal_subtype": "recognized_as",
  "detected_at": "2026-11-04T17:00:00+00:00",
  "company": {
    "name": "Sanofi",
    "domain": "sanofi.com"
  },
  "data": {
    "url": "https://www.prnewswire.com/news-releases/cns-summit-announces-sanofi-as-no-1-in-the-2026-digital-innovation-index-302929088.html",
    "title": "CNS Summit Announces Sanofi as No. 1 in the 2026 Digital Innovation Index",
    "excerpt": "BOSTON , Nov. 4, 2026 /PRNewswire/ -- Sanofi ranked first in the 2026 CNS Summit Digital Innovation Index, developed in collaboration with IDEA Pharma, a division of SAI MedPartners, placing in the top three in all three categories. The rankings were revealed today on the CNS Summit 2026 main stage at Encore Boston Harbor. Now in its 11th year, the Index ranks the top 30 pharmaceutical companies on digital innovation, using publicly reported initiatives and investments from July 2025 through July 2026. The 2026 top 10 are Sanofi, Eli Lilly, AstraZeneca, Chugai, Roche, Bristol Myers Squibb, Novo Nordisk, Johnson & Johnson, Boehringer Ingelheim and Merck KGaA. Category leaders were Roche in commercial, Novo Nordisk in clinical development and Recursion in research. \"Ranking first in the Pharmaceutical Digital Innovation Index reflects a shift we are proud of: digital and AI at Sanofi are now a connected system spanning research, clinical development and commercial operations. This is what allows us to move beyond AI experimentation to AI that delivers impact at scale, so that scientific breakthroughs reach patients faster,\" said Emmanuel Frenehard, Chief Digital Officer, Sanofi. CNS Summit's Chairman and Chief Curator, Dr. Amir Kalali, said, \"Digital innovation is becoming more and more important in research and development. We are pleased to continue to support this independent...",
    "summary": "Sanofi ranked first in the 2026 CNS Summit Digital Innovation Index.",
    "location": "Boston, Massachusetts, United States",
    "planning": false,
    "confidence": 0.95,
    "recognition": "No. 1 in the 2026 CNS Summit Digital Innovation Index",
    "published_at": "2026-11-04T17:00:00Z",
    "location_data": [
      {
        "city": "Boston",
        "state": "Massachusetts",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-11-04",
    "article_sentence": "Sanofi ranked first in the 2026 CNS Summit Digital Innovation Index, developed in collaboration with IDEA Pharma, a division of SAI MedPartners, placing in the top three in all three categories."
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.